Loading...
Docoh

Aptevo Therapeutics (APVO)

399 filings

Page 6 of 20
Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
DEFA14A
APVO Aptevo Therapeutics Inc
10 Feb 21
Additional proxy soliciting materials
12:00am
DFAN14A
APVO Aptevo Therapeutics Inc
9 Feb 21
Additional proxy materials by non-management
8:30am
SC 13D/A
APVO Aptevo Therapeutics Inc
9 Feb 21
Aptevo Therapeutics / TANG CAPITAL PARTNERS ownership change
8:30am
EFFECT
APVO Aptevo Therapeutics Inc
21 Dec 20
Notice of effectiveness
12:16am
UPLOAD
APVO Aptevo Therapeutics Inc
17 Dec 20
Letter from SEC
12:00am
CORRESP
APVO Aptevo Therapeutics Inc
17 Dec 20
Correspondence with SEC
12:00am
8-K
APVO Aptevo Therapeutics Inc
14 Dec 20
Entry into a Material Definitive Agreement
9:07am
S-3
APVO Aptevo Therapeutics Inc
14 Dec 20
Shelf registration
8:56am
8-K
APVO Aptevo Therapeutics Inc
14 Dec 20
Other Events
7:56am
8-K
APVO Aptevo Therapeutics Inc
2 Dec 20
Announces the Launch of Its Second Platform Technology
8:00am
8-K
APVO Aptevo Therapeutics Inc
30 Nov 20
Amendments to Articles of Incorporation or Bylaws
4:54pm
SC 13G/A
APVO Aptevo Therapeutics Inc
27 Nov 20
Aptevo Therapeutics / HIRSCHMAN ORIN ownership change
2:30pm
SC 13D/A
APVO Aptevo Therapeutics Inc
18 Nov 20
Aptevo Therapeutics / TANG CAPITAL PARTNERS ownership change
5:03pm
SC 13G
APVO Aptevo Therapeutics Inc
16 Nov 20
Aptevo Therapeutics / RTW INVESTMENTS ownership change
11:02am
8-K
APVO Aptevo Therapeutics Inc
16 Nov 20
Regulation FD Disclosure
8:17am
10-Q
2020 Q3
APVO Aptevo Therapeutics Inc
10 Nov 20
Quarterly report
5:29pm
8-K
APVO Aptevo Therapeutics Inc
10 Nov 20
Aptevo Therapeutics Reports Third Quarter Financial Results and Provides Business Update
4:58pm
8-K
APVO Aptevo Therapeutics Inc
9 Nov 20
Aptevo Therapeutics Announces Second Complete Remission
7:30am
8-A12B
APVO Aptevo Therapeutics Inc
9 Nov 20
Registration of securities on exchange
6:08am
8-K
APVO Aptevo Therapeutics Inc
9 Nov 20
Entry into a Material Definitive Agreement
6:05am